Ensign Group price target raised to $205 from $195 at UBS

UBS analyst AJ Rice raised the firm’s price target on Ensign Group (ENSG) to $205 from $195 and keeps a Buy rating on the shares. During investor meetings, the company highlighted the positive operating momentum within the skilled nursing facility industry which continues to recover post-pandemic, the analyst tells investors in a research note. After a challenging period in the pandemic, key policymakers have turned more favorable in their views of the nursing home space, UBS says.